Canopy Biosciences has acquired 2 companies of its own.
Canopy Biosciences has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (50%) and medical products (50%).
4340 Duncan Avenue,
St. Louis, Missouri
63110
United States,
www.canopybiosciences.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2019-12-04 |
Core Diagnostics · Life Science
Hayward, California · www.corediagnostics.net Core Diagnostics is a California licensed CLIA-certified laboratory offering biomarker analysis and translational research support for studies ranging from early discovery to analyses of Phase III clinical trial samples. Core’s research group works with clients to develop biomarker strategies and assays collaboratively by functioning seamlessly as an extension of their team and executing on their requirements. |
- | Add-on Acquisition | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
